Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia
Abstract Achondroplasia (ACH) is the most common short-limbed skeletal dysplasia caused by gain-of-function mutations in the fibroblast growth factor receptor 3 (FGFR3). No effective FGFR3-targeted therapies for ACH are currently available. By drug repositioning strategies, we identified that mecloz...
Guardado en:
Autores principales: | Masaki Matsushita, Ryusaku Esaki, Kenichi Mishima, Naoki Ishiguro, Kinji Ohno, Hiroshi Kitoh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d105b8f11c35482fbfa7a96465102627 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluating the results of long tubular bone distraction with an advanced rod monolateral external fixator for achondroplasia
por: Bolatbek Dossanov, et al.
Publicado: (2021) -
Genetic determinants of trabecular and cortical volumetric bone mineral densities and bone microstructure.
por: Lavinia Paternoster, et al.
Publicado: (2013) -
Association of short sleep duration and trabecular bone score
por: Yi-Chih Shiao, et al.
Publicado: (2021) -
Determinants of microdamage in elderly human vertebral trabecular bone.
por: Hélène Follet, et al.
Publicado: (2013) -
Mechanical adaptation of trabecular bone morphology in the mammalian mandible
por: Peter J. Watson, et al.
Publicado: (2018)